See more : Toho Zinc Co., Ltd. (5707.T) Income Statement Analysis – Financial Results
Complete financial analysis of China Meheco Group Co., Ltd. (600056.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Meheco Group Co., Ltd., a leading company in the Medical – Distribution industry within the Healthcare sector.
- Synopex Inc. (025320.KQ) Income Statement Analysis – Financial Results
- Waterco Limited (WAT.AX) Income Statement Analysis – Financial Results
- Austevoll Seafood ASA (AUSS.OL) Income Statement Analysis – Financial Results
- Dingdong (Cayman) Limited (DDL) Income Statement Analysis – Financial Results
- Slave Lake Zinc Corp. (SLZNF) Income Statement Analysis – Financial Results
China Meheco Group Co., Ltd. (600056.SS)
About China Meheco Group Co., Ltd.
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company imports and exports China national medicines and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral drugs; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products and raw materials; chemical raw materials; and nutritional and other healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 38.82B | 37.59B | 36.23B | 39.31B | 35.28B | 31.01B | 30.10B | 25.74B | 20.57B | 17.86B | 14.83B | 9.90B | 7.27B | 6.26B | 4.79B | 3.08B | 2.48B | 2.70B | 1.93B | 2.17B | 2.67B | 2.31B | 2.48B | 1.40B | 1.47B | 1.74B | 1.96B | 2.28B | 1.24B | 1.30B |
Cost of Revenue | 34.47B | 32.85B | 31.02B | 32.51B | 28.81B | 24.51B | 25.79B | 22.70B | 18.05B | 15.79B | 12.95B | 8.80B | 6.35B | 5.65B | 4.26B | 2.63B | 2.17B | 2.47B | 1.73B | 2.10B | 2.63B | 2.24B | 2.42B | 1.37B | 1.43B | 1.70B | 1.91B | 2.21B | 1.17B | 1.21B |
Gross Profit | 4.35B | 4.75B | 5.22B | 6.80B | 6.48B | 6.50B | 4.31B | 3.04B | 2.52B | 2.07B | 1.88B | 1.10B | 921.48M | 610.06M | 532.63M | 448.12M | 304.61M | 234.96M | 202.79M | 72.47M | 41.43M | 67.74M | 62.55M | 32.97M | 38.44M | 39.54M | 48.70M | 67.74M | 66.29M | 86.44M |
Gross Profit Ratio | 11.22% | 12.63% | 14.40% | 17.30% | 18.35% | 20.95% | 14.32% | 11.79% | 12.25% | 11.58% | 12.66% | 11.10% | 12.68% | 9.75% | 11.12% | 14.55% | 12.31% | 8.69% | 10.51% | 3.33% | 1.55% | 2.94% | 2.52% | 2.35% | 2.61% | 2.27% | 2.49% | 2.97% | 5.36% | 6.66% |
Research & Development | 123.96M | 77.33M | 57.38M | 83.80M | 107.54M | 86.00M | 134.90M | 71.17M | 49.10M | 52.96M | 31.54M | 57.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 832.06M | 201.59M | 179.83M | 253.72M | 227.20M | 199.74M | 121.45M | 193.92M | 153.44M | 103.71M | 159.32M | 50.42M | 35.78M | 34.06M | 82.01M | 76.93M | 26.73M | 70.60M | 61.58M | 36.37M | 33.97M | 25.57M | 42.64M | 12.81M | 3.15M | 8.62M | 5.55M | 2.36M | 4.10M | 3.36M |
Selling & Marketing | 996.79M | 1.95B | 2.20B | 2.48B | 3.44B | 3.51B | 1.59B | 857.77M | 823.74M | 688.06M | 626.23M | 366.17M | 336.02M | 210.13M | 200.85M | 165.66M | 93.22M | 78.62M | 71.26M | 15.26M | 10.49M | 9.94M | 10.64M | 11.59M | 15.94M | 13.33M | 7.13M | 2.49M | 2.72M | 3.46M |
SG&A | 2.56B | 2.15B | 2.38B | 2.74B | 3.67B | 3.71B | 1.71B | 1.05B | 977.18M | 791.76M | 785.55M | 416.59M | 371.80M | 244.19M | 282.86M | 242.60M | 119.95M | 149.22M | 132.84M | 51.63M | 44.45M | 35.50M | 53.28M | 24.40M | 19.09M | 21.95M | 12.68M | 4.85M | 6.82M | 6.82M |
Other Expenses | 0.00 | 877.71M | 728.47M | 653.43M | 618.44M | 42.15M | -7.48M | 52.70M | 26.54M | 18.55M | 14.48M | 5.26M | 2.07M | 6.18M | 984.54K | -4.70M | 4.51M | -156.04K | 1.49M | 722.45K | 2.75M | 1.22M | 3.36M | 10.29M | 2.12M | 339.64K | 4.04M | 918.76K | 504.58K | 528.54K |
Operating Expenses | 2.71B | 3.11B | 3.17B | 3.48B | 4.39B | 4.44B | 2.30B | 1.56B | 1.38B | 1.15B | 1.10B | 515.55M | 461.43M | 325.28M | 288.40M | 247.02M | 176.84M | 151.60M | 135.31M | 54.41M | 46.16M | 37.30M | 54.98M | 23.47M | 20.10M | 23.34M | 14.47M | 5.77M | 7.32M | 7.34M |
Cost & Expenses | 37.15B | 35.95B | 34.18B | 35.99B | 33.20B | 28.95B | 28.09B | 24.26B | 19.43B | 16.94B | 14.05B | 9.32B | 6.81B | 5.97B | 4.55B | 2.88B | 2.35B | 2.62B | 1.86B | 2.16B | 2.68B | 2.28B | 2.48B | 1.39B | 1.45B | 1.73B | 1.92B | 5.77M | 7.32M | 7.34M |
Interest Income | 46.35M | 35.23M | 28.18M | 32.95M | 18.51M | 24.95M | 27.68M | 28.01M | 24.22M | 30.63M | 41.63M | 34.25M | 11.97M | 7.91M | 5.47M | 6.33M | 6.61M | 4.15M | 4.89M | 6.42M | 3.61M | 6.99M | 5.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.19 |
Interest Expense | 230.84M | 217.58M | 221.77M | 244.48M | 164.43M | 125.86M | 79.24M | 72.78M | 93.00M | 134.87M | 179.14M | 20.99M | 20.59M | 17.79M | 3.18M | 972.00K | 3.20M | 3.00M | 1.59M | 491.28K | 2.07M | 10.96M | 5.36M | 150.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.17M |
Depreciation & Amortization | 431.02M | 411.06M | 297.13M | 253.39M | 243.69M | 222.74M | 205.87M | 146.29M | 169.79M | 146.78M | 143.71M | 26.69M | 16.93M | 14.92M | 16.85M | 15.27M | 13.75M | 14.32M | 13.34M | 5.46M | 2.60M | 1.97M | 1.71M | 1.74M | 1.71M | 1.02M | -32.37M | -75.82M | -73.06M | -60.27M |
EBITDA | 2.27B | 1.76B | 1.44B | 2.35B | 2.08B | 2.67B | 2.36B | 1.67B | 1.21B | 1.08B | 1.05B | 644.87M | 452.89M | 355.52M | 323.75M | 264.77M | 335.93M | 133.51M | 118.49M | 20.53M | 53.16M | 64.07M | 62.36M | 16.89M | 20.05M | 17.99M | 34.23M | -5.77M | -7.32M | -7.34M |
EBITDA Ratio | 5.86% | 5.82% | 6.66% | 9.13% | 6.51% | 9.28% | 7.88% | 6.67% | 6.70% | 6.30% | 6.63% | 6.51% | 6.81% | 5.98% | 7.02% | 9.56% | 13.96% | 4.88% | 6.14% | 0.94% | 1.99% | 2.78% | 2.51% | 0.80% | 1.36% | 0.99% | 1.75% | -0.25% | -0.59% | -0.57% |
Operating Income | 1.67B | 1.84B | 2.14B | 3.37B | 1.69B | 2.29B | 2.01B | 1.39B | 914.55M | 777.32M | 709.65M | 535.66M | 412.74M | 316.84M | 302.74M | 253.35M | 317.92M | 114.66M | 104.40M | 14.58M | 47.08M | 51.10M | 55.04M | 29.65M | 34.44M | 50.77M | 66.60M | 70.05M | 65.74M | 52.92M |
Operating Income Ratio | 4.31% | 4.89% | 5.90% | 8.57% | 4.79% | 7.39% | 6.66% | 5.39% | 4.45% | 4.35% | 4.79% | 5.41% | 5.68% | 5.06% | 6.32% | 8.23% | 12.84% | 4.24% | 5.41% | 0.67% | 1.76% | 2.22% | 2.22% | 2.12% | 2.34% | 2.91% | 3.40% | 3.08% | 5.31% | 4.07% |
Total Other Income/Expenses | -31.78M | -220.85M | -435.37M | -353.64M | -161.89M | 42.15M | -59.50M | 17.63M | 17.34M | 18.39M | -122.26M | -131.12M | 1.99M | 5.97M | 79.70M | -4.82M | 194.41M | 31.08M | 33.75M | 0.00 | 1.41M | 36.19K | 247.19K | 8.05M | 2.12M | 339.64K | 3.49M | 0.00 | 0.00 | 0.00 |
Income Before Tax | 1.64B | 1.20B | 940.11M | 1.93B | 1.69B | 2.33B | 2.00B | 1.44B | 931.88M | 795.71M | 722.80M | 540.42M | 414.73M | 322.81M | 303.73M | 248.53M | 322.19M | 114.47M | 103.56M | 14.58M | 48.49M | 51.14M | 55.29M | 37.70M | 36.56M | 51.11M | 70.10M | 70.05M | 65.74M | 52.92M |
Income Before Tax Ratio | 4.23% | 3.18% | 2.59% | 4.90% | 4.80% | 7.53% | 6.64% | 5.59% | 4.53% | 4.46% | 4.87% | 5.46% | 5.71% | 5.16% | 6.34% | 8.07% | 13.02% | 4.23% | 5.37% | 0.67% | 1.82% | 2.22% | 2.23% | 2.69% | 2.48% | 2.93% | 3.58% | 3.08% | 5.31% | 4.07% |
Income Tax Expense | 398.44M | 308.16M | 225.83M | 539.19M | 437.58M | 512.38M | 455.29M | 320.09M | 213.11M | 182.02M | 186.38M | 130.76M | 93.94M | 72.38M | 70.50M | 52.43M | 59.16M | 28.22M | 18.69M | 3.88M | 5.60M | 5.85M | 6.26M | 5.45M | 4.92M | 7.24M | 8.25M | 23.12M | 21.69M | 17.46M |
Net Income | 1.05B | 735.60M | 647.06M | 1.31B | 981.35M | 1.54B | 1.30B | 948.14M | 614.45M | 550.18M | 484.83M | 348.56M | 269.00M | 194.94M | 189.27M | 162.96M | 234.85M | 72.31M | 72.58M | 6.55M | 42.42M | 45.13M | 49.03M | 32.25M | 31.63M | 43.88M | 61.85M | 46.93M | 44.05M | 35.46M |
Net Income Ratio | 2.70% | 1.96% | 1.79% | 3.33% | 2.78% | 4.98% | 4.31% | 3.68% | 2.99% | 3.08% | 3.27% | 3.52% | 3.70% | 3.11% | 3.95% | 5.29% | 9.49% | 2.68% | 3.76% | 0.30% | 1.59% | 1.96% | 1.97% | 2.30% | 2.15% | 2.52% | 3.16% | 2.06% | 3.56% | 2.73% |
EPS | 0.70 | 0.49 | 0.43 | 0.88 | 0.66 | 1.03 | 0.88 | 0.66 | 0.43 | 0.40 | 0.38 | 0.32 | 0.31 | 0.22 | 0.22 | 0.19 | 0.27 | 0.09 | 0.06 | 0.01 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | 0.06 | 0.08 | 0.07 | 0.06 |
EPS Diluted | 0.70 | 0.49 | 0.43 | 0.88 | 0.66 | 1.03 | 0.88 | 0.66 | 0.43 | 0.40 | 0.38 | 0.32 | 0.31 | 0.22 | 0.22 | 0.19 | 0.27 | 0.09 | 0.06 | 0.01 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | 0.06 | 0.08 | 0.07 | 0.06 |
Weighted Avg Shares Out | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.44B | 1.42B | 1.38B | 1.28B | 1.28B | 870.65M | 870.68M | 870.63M | 870.67M | 872.31M | 870.61M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M |
Weighted Avg Shares Out (Dil) | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.50B | 1.44B | 1.42B | 1.38B | 1.28B | 1.28B | 870.65M | 870.68M | 870.63M | 870.67M | 872.31M | 870.61M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M | 621.86M |
Source: https://incomestatements.info
Category: Stock Reports